Stock listing
Natera, Inc.
- Ticker
- NASDAQ:NTRA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Natera, Inc.
Natera, Inc. is a publicly traded company listed under the ticker NTRA, operating in the American market. Natera specializes in genetic testing and diagnostics, providing services that support reproductive health and oncology.
Latest news from Natera, Inc.
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
Oct 9, 2026
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Oct 7, 2026
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
Oct 6, 2026
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Oct 5, 2026